Resolve Stroke

Resolve Stroke is a clinical-stage medtech company based in Paris, France, focused on enhancing stroke diagnosis and neurocritical care through advanced ultrasound imaging technology. As a spin-off from Sorbonne University, the company utilizes Ultrasound Localization Microscopy (ULM) to create high-resolution, 3D images of blood flow, improving the speed and accuracy of stroke assessments. The company's key innovations include the RS USP (Delayed Ischemic Risk Score), which helps predict the risk of delayed brain damage, and the RS LVO (Arterial Permeability Index), which evaluates blood supply blockages in major brain vessels. Resolve Stroke operates on a B2B model, targeting healthcare providers and hospitals that require sophisticated diagnostic tools for stroke and neurological conditions. Their ongoing clinical trials with the SYLVER platform aim to advance the use of transcranial ultrasound data in neurocritical care. Led by a team with extensive expertise in healthcare and technology, Resolve Stroke is committed to transforming neurological care and has received recognition for its contributions to medical imaging.

• Employees 15
• Founded 2022